BiFC and FACS-based CRISPR screening revealed that QKI promotes PABPN1 LLPS in colorectal cancer cells
Protein & Cell · 2025
DOI: 10.1093/procel/pwaf022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, 2025. Verfasst von Mengxia Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, Department of Biochemistry, Innovation Cent…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, RNA-Binding Proteins, Poly(A)-Binding Protein I, CRISPR-Cas Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Guangdong Science and Technology Department.
Abstract (Originalsprache)
Protein liquid–liquid phase separation (LLPS), a pivotal phenomenon intricately linked to cellular processes, is regulated by various other proteins. However, there is still a lack of high-throughput methods for screening protein regulators of LLPS in target proteins. Here, we developed a CRISPR/Cas9-based screening method to identify protein phase separation regulators by integrating bimolecular fluorescence complementation (BiFC) and fluorescence-activated cell sorting (FACS). Using this newly developed method, we screened the RNA-binding proteins that regulate PABPN1 phase separation and identified the tumor suppressor QKI as a promoter of PABPN1 phase separation. Furthermore, QKI exhibits decreased expression levels and diminished nuclear localization in colorectal cancer cells, resulting in reduced PABPN1 phase separation, which, in turn, promotes alternative polyadenylation (APA), cell proliferation, and migration in colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Biocontrol, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, Department of Biochemistry, Innovation Center for Evolutionary Synthetic Biology, School of Life Sciences, Sun Ya…
- Department of Hepatology, Guangzhou Institute of Clinical Medicine of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou 510440, China.
- Sun Yat-sen University Institute of Advanced Studies, Hong KongSAR, China.
ORCID-Profile: Mengxia Li, Zhijie Hu, Anlong Xu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Guangdong Science and Technology Department
Zitieren
APA
Li, M., Hu, Z., Huang, Y., Han, Y., Liang, C., Liu, Y., Wu, R., Lu, X., Deng, K., Liu, S., Ou, X., Li, Y., Liu, C., Li, X., Liang, J., Fu, Y., & Xu, A. (2025). BiFC and FACS-based CRISPR screening revealed that QKI promotes PABPN1 LLPS in colorectal cancer cells. Protein & Cell. https://doi.org/10.1093/procel/pwaf022
Vancouver
Li M, Hu Z, Huang Y, Han Y, Liang C, Liu Y, et al. BiFC and FACS-based CRISPR screening revealed that QKI promotes PABPN1 LLPS in colorectal cancer cells. Protein & Cell. 2025. doi:10.1093/procel/pwaf022
BibTeX
@article{Li2025,
author = {Li, Mengxia and Hu, Zhijie and Huang, Yingye and Han, Yuting and Liang, Cheng and Liu, Yuchi and Wu, Runze and Lu, Xin and Deng, Ke and Liu, Susu and Ou, Xin and Li, Yuwei and Liu, Chao and Li, Xuening and Liang, Jingting and Fu, Yonggui and Xu, Anlong},
title = {BiFC and FACS-based CRISPR screening revealed that QKI promotes PABPN1 LLPS in colorectal cancer cells},
journal = {Protein & Cell},
year = {2025},
doi = {10.1093/procel/pwaf022}
}
EUVIMED